Clinical research support and collaboration for nhgri protocols: task area 2 - regulatory support for IND and IDE submissions
Ended Awarded Last action
- Contract number
- 75N92023F00002
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $164,130
Award facts
- Contract value 100% obligated
- $164,130.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Time and Materials
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Definitize Change Order | $54,301 | |
| Original award | $109,829 |
About this award
This is a $164,130.00 Delivery Order contract awarded to The Emmes Company LLC by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract is for clinical research support and regulatory collaboration for NHGRI protocols, with a focus on regulatory support for Investigational New Drug (IND) and Investigational Device Exemption (IDE) submissions. This work is being performed under NHGRI's larger $4 million Clinical Research Support and Collaboration for NHGRI Protocols indefinite delivery vehicle. The contract is a Time and Materials type and does not have a set-aside designation. The Emmes Company LLC is a global clinical research organization that has held multiple prime contracts and subcontracts with NIH institutes to provide data management, statistical analysis, and clinical trial operations support for various public health research initiatives.
Quick answers
Who was awarded contract 75N92023F00002?
75N92023F00002 was awarded to The Emmes Company, LLC by National Heart Lung and Blood Institute (National Institutes of Health) on July 1, 2023.
How much is contract 75N92023F00002 worth?
The government has obligated $164,130 on 75N92023F00002.
Which agency awarded contract 75N92023F00002?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92023F00002, with funding from National Human Genome Research Institute (National Institutes of Health).
Is contract 75N92023F00002 an order under another contract?
Yes. 75N92023F00002 is a delivery order under 75N92023D00009, an indefinite delivery contract.
Was contract 75N92023F00002 competed?
The extent of competition for 75N92023F00002 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award